198 related articles for article (PubMed ID: 24287213)
1. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
4. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
5. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
6. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
[TBL] [Abstract][Full Text] [Related]
7. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
Verwaaijen EJ; Ma J; de Groot-Kruseman HA; Pieters R; van der Sluis IM; van Atteveld JE; Halton J; Fernandez CV; Hartman A; de Jonge R; Lequin MH; Te Winkel ML; Alos N; Atkinson SA; Barr R; Grant RM; Hay J; Huber AM; Ho J; Jaremko J; Koujok K; Lang B; Matzinger MA; Shenouda N; Rauch F; Rodd C; van den Heuvel-Eibrink MM; Pluijm SMF; Ward LM;
J Bone Miner Res; 2021 Dec; 36(12):2290-2299. PubMed ID: 34610647
[TBL] [Abstract][Full Text] [Related]
8. Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation.
Hardinger KL; Ho B; Schnitzler MA; Desai N; Lowell J; Shenoy S; Chapman W; Crippin JS
Liver Transpl; 2003 Aug; 9(8):857-62. PubMed ID: 12884200
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
10. Peak bone mineral density, lean body mass and fractures.
Boot AM; de Ridder MA; van der Sluis IM; van Slobbe I; Krenning EP; Keizer-Schrama SM
Bone; 2010 Feb; 46(2):336-41. PubMed ID: 19833245
[TBL] [Abstract][Full Text] [Related]
11. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone mineral density at different phases of therapy of childhood all.
Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
[TBL] [Abstract][Full Text] [Related]
13. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
16. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
17. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
[TBL] [Abstract][Full Text] [Related]
18. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD
J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786
[TBL] [Abstract][Full Text] [Related]
19. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
20. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
[Next] [New Search]